Genmab A/S (GMAB)
NASDAQ: GMAB
· Real-Time Price · USD
23.29
0.31 (1.35%)
At close: Aug 15, 2025, 3:59 PM
23.28
-0.02%
After-hours: Aug 15, 2025, 07:09 PM EDT
Genmab A/S Income Statement
Financials in DKK. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 22.32B | 21.53B | 19.76B | 18.97B | 17.76B | 16.47B | 17.02B | 16.37B | 15.33B | 14.6B | 11.99B | 10.21B | 9.02B | 8.48B | 7.91B | 7.32B | 10.8B |
Cost of Revenue | 842M | 985M | 774M | 601M | 432M | 247M | 121M | 21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 21.23B | 20.54B | 18.99B | 18.37B | 17.33B | 16.23B | 16.9B | 16.34B | 15.33B | 14.6B | 11.99B | 10.21B | 9.02B | 8.48B | 7.91B | 7.32B | 10.8B |
Operating Income | 6.27B | 6.88B | 6.39B | 5.97B | 5.62B | 5.24B | 6.24B | 5.23B | 5.01B | 5.11B | 3.25B | 3.46B | 3B | 3.02B | 3.1B | 3.06B | 6.77B |
Interest Income | 711M | 724M | 795M | 876M | 793M | 939M | 784M | 638M | 480M | 324M | 219M | 157M | 171M | 197M | 220M | 718M | 695M |
Pretax Income | 7.69B | 9.16B | 6.49B | 7.44B | 7.01B | 5.56B | 5.29B | 5.89B | 6.69B | 7.04B | 7.34B | 5.24B | 3.17B | 3.98B | 3.57B | 3.07B | 6.97B |
Net Income | 6.71B | 7.84B | 4.64B | 5.48B | 5.4B | 4.29B | 4.23B | 4.71B | 5.27B | 5.52B | 5.65B | 3.96B | 2.38B | 3.01B | 2.87B | 2.51B | 5.58B |
Selling & General & Admin | 3.13B | 3.87B | 3.55B | 3.52B | 3.48B | 3.3B | 3.28B | 3.12B | 2.9B | 2.68B | 2.27B | 1.9B | 1.53B | 1.28B | 1B | 841M | 756M |
Research & Development | 7.81B | 9.75B | 9.03B | 8.84B | 8.19B | 7.63B | 7.32B | 6.72B | 6.15B | 5.56B | 5.22B | 4.85B | 4.49B | 4.18B | 3.81B | 3.42B | 3.27B |
Other Expenses | 48M | 48M | 17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 10.99B | 13.66B | 12.6B | 12.36B | 11.67B | 10.93B | 10.61B | 9.84B | 9.05B | 8.24B | 7.49B | 6.75B | 6.02B | 5.46B | 4.81B | 4.26B | 4.03B |
Interest Expense | 96M | 95M | 47M | 37M | 25M | 27M | 26M | 24M | 23M | 21M | 19M | 17M | 441M | 440M | 440M | 1.16B | 937M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 15.12B | 14.82B | 13.55B | 13.14B | 12.08B | 11.15B | 10.71B | 9.84B | 9.05B | 8.24B | 7.49B | 6.75B | 6.02B | 5.46B | 4.81B | 4.26B | 4.03B |
Income Tax Expense | 978M | 1.32B | 1.85B | 1.96B | 1.6B | 1.27B | 1.06B | 1.18B | 1.42B | 1.51B | 1.69B | 1.28B | 794M | 975M | 695M | 555M | 1.39B |
Shares Outstanding (Basic) | 637.25M | 641.56M | 648.85M | 648.85M | 653.03M | 653.06M | 653.07M | 652.4M | 654.21M | 652.85M | 652.84M | 655.01M | 657.34M | 654.06M | 653.93M | 653.85M | 653.94M |
Shares Outstanding (Diluted) | 639.34M | 641.54M | 648.85M | 648.85M | 656.59M | 657.87M | 658.73M | 658.42M | 658.31M | 660.7M | 659.18M | 659.8M | 659.57M | 661.42M | 660.73M | 659.48M | 659.84M |
EPS (Basic) | 10.42 | 12.14 | 7.13 | 8.44 | 8.35 | 6.64 | 6.56 | 7.26 | 8.07 | 8.46 | 8.66 | 6.06 | 3.64 | 4.61 | 4.39 | 3.84 | 8.56 |
EPS (Diluted) | 10.42 | 12.13 | 7.11 | 8.39 | 8.28 | 6.58 | 6.49 | 7.18 | 7.99 | 8.38 | 8.58 | 6.01 | 3.60 | 4.55 | 4.35 | 3.80 | 8.48 |
EBITDA | 6.62B | 7.21B | 5.79B | 5.74B | 5.31B | 4.92B | 4.66B | 6.13B | 5.72B | 5.87B | 6.17B | 4.07B | 3.6B | 4.42B | 4.41B | 4.63B | 8.32B |
EBIT | 6.4B | 6.95B | 5.62B | 6.56B | 6.13B | 5.6B | 5.34B | 5.94B | 6.71B | 7.06B | 7.36B | 5.25B | 3.55B | 4.36B | 3.94B | 4.16B | 7.91B |
Depreciation & Amortization | 285M | 329M | 274M | 274M | 286M | 280M | 274M | 251M | 232M | 240M | 248M | 243.5M | 239M | 234.5M | 230M | 207.25M | 184.5M |